Xunbaihui Biotechnology Co.
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $2.9M
Investors
- 6
About Xunbaihui Biotechnology Co.
, Ltd. is a medical services company that focuses on cancer diagnosis and treatment. The founder of the company, Xiaole Liu, is a tenured professor at Harvard University and Professor of the Center for Epigenetics at Dana Farber Cancer Institute. The company was recognized as a national high-tech enterprise and the list of science and technology-based small and medium-sized enterprises.'s main product category are oncology antibody drugs. Products within include XBH25, XBH62, and XBH82. It also has the GV20 Genomics Platform and GV20 Artificial Intelligence Platform, which are used for tumor immune target tracking and cancer antibody drug discovery and development, such as CRISPR and Cas9 high-throughput screening services. The company's products have served cancer patients, pharmaceutical companies and research institutions.
Who invested in Xunbaihui Biotechnology Co.
6 investors across 2 rounds
See all investors in Xunbaihui Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xunbaihui Biotechnology Co.
Who invested in Xunbaihui Biotechnology Co.?
Xunbaihui Biotechnology Co. has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xunbaihui Biotechnology Co. raised?
Xunbaihui Biotechnology Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Xunbaihui Biotechnology Co. last raise money?
Xunbaihui Biotechnology Co.'s most recent round on record is a Series B, in Oct 2021.
What does Xunbaihui Biotechnology Co. do?
Xunbaihui Biotechnology Co. is a biotechnology company.
Where is Xunbaihui Biotechnology Co. headquartered?
Xunbaihui Biotechnology Co. is headquartered in Shanghai, China.
Which VCs invest in companies like Xunbaihui Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Xunbaihui Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Xunbaihui Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.